NCT06915025: An ongoing trial by Imunon
This trial is ongoing. It must report results 7 years, 10 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06915025 |
|---|---|
| Title | A Randomized Phase 3 Trial Evaluating the Safety & Efficacy of IP IMNN-001 Administered in Combination w/ Standard Neoadjuvant & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | July 9, 2025 |
| Completion date | Oct. 31, 2032 |
| Required reporting date | Oct. 31, 2033, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 23, 2025 |
| Days late | None |